Blockbuster Drugs 2010

This FREE downloadable report contains a compilation of the 100 blockbuster drugs with 2010 sales of more than US$ 1 bln each. The report has been published as a special issue of R&D Pipeline News on November 14, 2011 and has 24 pages. The reports lists in order of descending sales the 100 blockbuster drugs with information on

  • Drug name
  • Target
  • Class of compound
  • Company
  • Product Category
  • Source of information with hyperlink and sales figures

The report summarizes the TOP 10 best selling blockbuster drugs in 2010 separately for small molecules, antibodies & proteins, peptides and vaccines. In addition, sales of blockbuster drugs were analyzed by therapeutic area and within each therapeutic area split per product category, i.e. small molecules, antibodies, proteins, peptides and vaccines.

Top 10 Blockbuster Drugs 2010 per Product Category:

  • Small molecules
  • Recombinant Antibodies & Proteins
  • Peptides
  • Vaccines

2010 Blockbuster Drug Sales per Therapeutic Area and Product Category

The cumulative sales of US$ 249 bln of the 100 blockbuster drugs were allocated to the respective therapeutic areas and within each area to the product categories small molecules, antibodies, proteins, peptides, and vaccines.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up